The effectiveness of insulin glargine in addition to basic treatment with regular insulin on recovery of patients with diabetic ketoacidosis compared to regular insulin alone / Ahmed Mohamed Abdelbaky ; Supervised Ahmed Mowafy , Khaled Zein Eldeen , Amr Nawar
Material type:
- دراسة فعالية اضافة إنسولين الغلارجين إلي الإنسولين المائي علي تعافي مرضي الحماض الكيتوني السكري مقارنة باستعمال الإنسولين المائي فقط [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.08.M.Sc.2019.Ah.E (Browse shelf(Opens below)) | Not for loan | 01010110079828000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.08.M.Sc.2019.Ah.E (Browse shelf(Opens below)) | 79828.CD | Not for loan | 01020110079828000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine- Department of Critical Care Medicine
Diabetic Ketoacidosis (DKA) is a potentially fatal metabolic disorder presenting as a common cause of intensive care unit admission. The disorder can have significant mortality if misdiagnosed or mistreated. The main features of DKA are hyperglycemia, metabolic acidosis with a high anion gap and heavy ketonuria. Insulin Glargin is along-acting basal insulin analogue shows no plasma insulin peaks. Insulin glargin was reported to be safe and effective to be added to the standard protocols of DKA management giving the advantage of reducing time of recovery of DKA patients and facilitate the transition from intravenous insulin infusion to subcutaneous injection, with no increase in risks of hypoglycemia, nor hypokalemia
Issued also as CD
There are no comments on this title.